DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma
Clinical trial NCT02487017 · UNKNOWN
Trial details
- NCT number
- NCT02487017
- Sponsor
- Shenzhen Hornetcorn Bio-technology Company, LTD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2018-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.